This document is a publication of a European patent application (EP4337243A1) related to "Growth factor compositions for the treatment of eye disease." The applicant is Claris Biotherapeutics, Inc. The publication date is March 11, 2026. This is a notification of a granted patent, not a regulatory rule or enforcement action.

As this is a patent publication, there are no direct compliance obligations for regulated entities. However, companies operating in the pharmaceutical or biotechnology sectors, particularly those involved in ophthalmology treatments, should be aware of this patent as it may impact their intellectual property landscape and potential product development or licensing strategies.